Reduced sulfatide content in deferoxamine-induced senescent HepG2 cells

Ghislanzoni, S; Sarcinelli, GM; Bresci, A; Manetti, F; Polli, D; Tomassetti, A; Radice, MT; Bongarzone, I

Ghislanzoni, S (通讯作者),Fdn IRCCS Ist Nazl Tumori, Dept Adv Diagnost, Via G Amadeo 42, I-20133 Milan, Italy.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2023; 159 ():

Abstract

Iron chelators, such as deferoxamine, exert an anticancer effect by altering the activity of biomolecules critical for regulation of the cell cycle, c......

Full Text Link